| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$291 |
Update - Notification of buy-back - AMH
|
5 Nov 2025 9:10AM |
$1.065 |
$0.925 |
fallen by
13.15%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$58,691 |
CSL Capital Markets Day
|
5 Nov 2025 9:09AM |
$176.990 |
$122.550 |
fallen by
30.76%
|
|
CSL - Price-sensitive ASX Announcement
Full Release
Key Points
- CSL Seqirus is uniquely positioned to leverage strategic differentiation in the influenza vaccine market.
- The company employs advanced technologies like cell-based platforms and the MF59 adjuvant.
- CSL Seqirus aims to enhance its market share through operational and customer-focused strategies.
- Significant growth opportunities are anticipated from pandemic preparedness and advance purchase agreements.
- Recovery in the US market is expected to act as a growth accelerator in the medium term.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$7 |
Diamond Drilling Complete - Intersects BIF Outside Resource
|
5 Nov 2025 9:09AM |
$0.019 |
$0.014 |
fallen by
26.32%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drilling completed at Monument Gold Project in Laverton, WA.
- Seven holes drilled for a total of 1,230 meters targeting Banded Iron Formation (BIF).
- Drilling took place outside the current 154,000-ounce inferred gold resource.
- Korong and Waihi deposits explored for resource expansion.
- Promising intersections with altered BIF, veining, and sulphides.
- Only 10% of the 20km BIF trend has been drilled.
- Continued reverse circulation drilling as part of a 10,000-meter program.
- Future exploration targets include untested structures along the BIF trend.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Galan Lithium Limited (GLN) ORDINARY FULLY PAID |
Materials |
$411 |
Early Completion of Strategic Placement
|
5 Nov 2025 9:07AM |
$0.150 |
$0.325 |
risen by
116.67%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$130 |
Change of Director's Interest Notice - DF
|
5 Nov 2025 9:07AM |
$0.430 |
$0.440 |
risen by
2.33%
|
|
| Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$65 |
Major Regulatory Milestone Secured at Idenburg Gold Project
|
5 Nov 2025 9:06AM |
$0.145 |
$0.155 |
risen by
6.90%
|
|
FEG - Price-sensitive ASX Announcement
Full Release
Key Points
- PIPPIB approval secured over 9,000 hectares at Idenburg Gold Project.
- Reclassification to Production Forestry enabling environmental permitting and licensing.
- Idenburg Project covers 95,280 ha with significant gold and copper potential.
- JORC Inferred Resource includes 540,000 oz Au and 468,000 oz Ag.
- Project benefits from infrastructure access via Trans-Papuan Highway.
- 32-hole drilling program underway targeting high-grade zones.
- Strategic regulatory milestone de-risks permitting process and advances development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$32 |
International Rare Earths Conference Presentation
|
5 Nov 2025 9:05AM |
$0.074 |
$0.110 |
risen by
48.65%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$760 |
Update - Notification of buy-back - RF1
|
5 Nov 2025 9:03AM |
$3.300 |
$3.650 |
risen by
10.61%
|
|
| Red Mountain Mining Limited (RMX) ORDINARY FULLY PAID |
Materials |
$12 |
RMXFF set to commence trading on US stock exchange
|
5 Nov 2025 9:02AM |
$0.030 |
$0.012 |
fallen by
61.67%
|
|
RMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Mountain Mining Limited (ASX: RMX) is preparing for a US Stock Exchange listing under the code RMXFF.
- The company has appointed a US-based markets advisory team to assist with the listing process on the OTCQB.
- Red Mountain has acquired three US antimony assets in Tier-1 mining districts since mid-September 2025.
- The company is involved in the Armidale Antimony-Gold Project in New South Wales, demonstrating high-grade mineralization.
- The US government is focused on building a domestic supply chain for antimony, providing Red Mountain potential access to federal financial support.
- There is an acute supply shortage of antimony globally, with China, Russia, and Tajikistan controlling 90% of production.
- Red Mountain expects to confirm the RMXFF listing date shortly.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$29 |
Letter to CDI Holders and CDI Voting Instruction Form
|
5 Nov 2025 9:02AM |
$0.052 |
$0.088 |
risen by
69.23%
|
|
| Mont Royal Resources Limited (MRZ) ORDINARY FULLY PAID |
Materials |
$24 |
Mont Royal Re-Lists on ASX Following Transformational Merger
|
5 Nov 2025 9:01AM |
$0.041 |
$0.125 |
risen by
204.88%
|
|
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$29 |
Notice of Special Meeting/Proxy Form
|
5 Nov 2025 9:00AM |
$0.052 |
$0.088 |
risen by
69.23%
|
|
| Osmond Resources Limited (OSM) ORDINARY FULLY PAID |
Materials |
$104 |
OSM Corporate Presentation - November 2025
|
5 Nov 2025 9:00AM |
$0.990 |
$0.750 |
fallen by
24.24%
|
|
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$206 |
2nd Distributor in Canada, Entire $75m Market Now Covered
|
5 Nov 2025 8:59AM |
$1.160 |
$0.755 |
fallen by
34.91%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell appointed a second Canadian distributor for Remplirâ„¢.
- Full national distribution coverage in the US$75 million Canadian market.
- Ontario-based distributor to cover provinces outside Alberta and British Columbia.
- Initial Canadian sales expected following promotional activities.
- Existing US-based marketing teams to support Canadian rollout.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$111 |
AGM Presentation
|
5 Nov 2025 8:58AM |
$0.405 |
$0.370 |
fallen by
8.64%
|
|
| Lotus Resources Limited (LOT) ORDINARY FULLY PAID |
Energy |
$180 |
Application for quotation of securities - LOT
|
5 Nov 2025 8:57AM |
$0.190 |
$0.660 |
risen by
247.37%
|
|
| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$53 |
Sampling program completed at REE-Uranium Project California
|
5 Nov 2025 8:57AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$238 |
Drilling Underway to Expand Tin-Silver-Tungsten Zones
|
5 Nov 2025 8:56AM |
$0.072 |
$0.240 |
risen by
233.33%
|
|
SKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Major new drilling program at Tallebung Tin Project.
- Over 100 drill-holes planned, including reverse circulation and diamond drilling.
- Targeting resource extensions and supporting updated Mineral Resource Estimate.
- First drill results expected in December.
- Program follows successful 143-hole campaign.
- Focus on expanding high-grade tin-silver-tungsten zones.
- Project aims to meet demand for tin in electronics and renewable energy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,859 |
Notification of cessation of securities - MFG
|
5 Nov 2025 8:54AM |
$9.570 |
$9.770 |
risen by
2.09%
|
|
| Tinybeans Group Ltd (TNY) ORDINARY FULLY PAID |
Communication Services |
$15 |
Investor Webinar
|
5 Nov 2025 8:54AM |
$0.140 |
$0.080 |
fallen by
42.86%
|
|
| Hansen Technologies Limited (HSN) ORDINARY FULLY PAID |
Information Technology |
$851 |
Hansen to Acquire Digitalk
|
5 Nov 2025 8:54AM |
$5.580 |
$4.160 |
fallen by
25.45%
|
|
HSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Hansen Technologies to acquire 100% of Digitalk.
- Enterprise value of £33.1 million, funded by cash and debt.
- Transaction to be accretive to earnings per share immediately.
- Completion expected by the end of 2025.
- Digitalk complements Hansen's Global Communications Suite.
- Acquisition expands Hansen's leadership in communications and media.
- Digitalk serves 150 customers in over 30 countries.
- Regulatory approvals pending for acquisition completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,859 |
Update - Notification of buy-back - MFG
|
5 Nov 2025 8:53AM |
$9.570 |
$9.770 |
risen by
2.09%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$25,205 |
Notification of cessation of securities - BXB
|
5 Nov 2025 8:52AM |
$23.410 |
$18.870 |
fallen by
19.39%
|
|
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$32 |
Change of Director's Interest Notice - S Evans
|
5 Nov 2025 8:51AM |
$0.430 |
$0.430 |
fallen by
0%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$27 |
Second part of HERACLES clinical trial begins
|
5 Nov 2025 8:51AM |
$0.092 |
$0.088 |
fallen by
4.35%
|
|
NOX - Price-sensitive ASX Announcement
Full Release
Key Points
- Second part of HERACLES clinical trial begins.
- HERACLES trial tests SOF-SKNâ„¢ for autoimmune diseases.
- Study conducted in Australia, leveraging local expertise.
- Successful first part results allow skipping lowest doses.
- Trial involves multiple doses over a longer period.
- Collaboration with Doherty Clinical Trials in Melbourne.
- SOF-SKN aims at treating chronic conditions like CLE.
- Global CLE market is over US$3.3 billion.
- Sofraâ„¢ technology potential for other diseases like diabetes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.